Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate the Safety”

Showing 20 of 0 results

Not applicableUnknownNCT03307213
What this trial is testing

BioFreedom QCA Study in CAD Patients

Who this might be right for
Coronary Artery DiseaseCardiac DeathMyocardial Infarction
Biosensors Europe SA 200
Testing effectiveness (Phase 2)Looking for participantsNCT07259213
What this trial is testing

Terbium 161 (161Tb)-RAD402 in Participants With CRPC

Who this might be right for
Castration-resistant Prostate Cancer
Radiopharm Theranostics, Ltd 73
Testing effectiveness (Phase 2)WithdrawnNCT04734860
What this trial is testing

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms

Who this might be right for
Covid19
Sorrento Therapeutics, Inc.
Large-scale testing (Phase 3)WithdrawnNCT02015780
What this trial is testing

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Takeda
Large-scale testing (Phase 3)Study completedNCT00605280
What this trial is testing

A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Who this might be right for
Macular Edema Associated With Diabetes Mellitus
Pfizer 317
Testing effectiveness (Phase 2)Looking for participantsNCT06712680
What this trial is testing

A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes

Who this might be right for
Solid Tumor
Sichuan Huiyu Pharmaceutical Co., Ltd 115
Not applicableStudy completedNCT00699179
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,308
Early research (Phase 1)Study completedNCT02345408
What this trial is testing

Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Amgen 54
Testing effectiveness (Phase 2)Study completedNCT01625689
What this trial is testing

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Who this might be right for
Influenza
PATH Vaccine Solutions 309
Large-scale testing (Phase 3)Study completedNCT07420491
What this trial is testing

The Efficacy and Safety of Reconyl in Acute Cough Treatment

Who this might be right for
Cough
Dexa Medica Group 144
Early research (Phase 1)Study completedNCT07307274
What this trial is testing

SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults

Who this might be right for
HealthyOverweight and Obese Adults
Syntis Bio 55
Testing effectiveness (Phase 2)Study completedNCT00592774
What this trial is testing

Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)

Who this might be right for
Neuralgia
Eisai Inc. 146
Early research (Phase 1)Looking for participantsNCT07363590
What this trial is testing

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

Who this might be right for
Systemic Lupus ErythematosusRheumatoid Arthritis
Merck Sharp & Dohme LLC 21
Early research (Phase 1)Study completedNCT06067490
What this trial is testing

A Phase I Study of RC1416 Injection

Who this might be right for
Healthy Volunteers
Nanjing RegeneCore Biotech Co., Ltd. 48
Early research (Phase 1)Study completedNCT02873260
What this trial is testing

Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT01235559
What this trial is testing

RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 604
Not applicableStudy completedNCT05777759
What this trial is testing

Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

Who this might be right for
Chin AugmentationChin Retrusion
Galderma R&D 175
Large-scale testing (Phase 3)Ended earlyNCT01330355
What this trial is testing

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis

Who this might be right for
Bacterial Conjunctivitis
Bausch & Lomb Incorporated 33
Large-scale testing (Phase 3)Study completedNCT00560378
What this trial is testing

Long-term Safety of Protopic in Atopic Eczema

Who this might be right for
Dermatitis, AtopicEczema, Atopic
Astellas Pharma Inc 789
Testing effectiveness (Phase 2)Study completedNCT00001789
What this trial is testing

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

Who this might be right for
Glomerulonephritis, MembranoproliferativeLupus Nephritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation